Mesenchymal Stem Cell Therapy for Lung Rejection

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

August 12, 2021

Study Completion Date

August 12, 2021

Conditions
Lung Transplant RejectBronchiolitis Obliterans
Interventions
BIOLOGICAL

Mesenchymal stem cell 0.5

0.5 million MSC per Kg will be infused intravenously. Product will be infused at the rate of 2 - 3 ml/minute during the first 15 minutes and may be adjusted up to 5ml/minutes if tolerable. It is anticipated that the infusion will be completed within approximately 3 hours.

BIOLOGICAL

Mesenchymal stem cell 1.0

1 million MSC per Kg will be infused intravenously. Product will be infused at the rate of 2 - 3 ml/minute during the first 15 minutes and may be adjusted up to 5ml/minutes if tolerable. It is anticipated that the infusion will be completed within approximately 3 hours.

Trial Locations (1)

32224

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER